Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,180 | 39,520 | 34,000 | 39,750 | 45,580 |
| Receivables | 6,670 | 7,990 | 10,590 | 3,890 | 6,470 |
| Inventories | 3,140 | 4,080 | N/A | 4,850 | 3,710 |
| Other current assets | 2,640 | 1,710 | 10 | 2,340 | 2,810 |
| TOTAL | $45,630 | $53,300 | $44,600 | $50,830 | $58,570 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 11,780 | 12,210 | 11,510 | 12,300 | 13,010 |
| TOTAL | $11,780 | $12,210 | $11,510 | $12,300 | $13,010 |
| Total Assets | $59,390 | $67,660 | $58,260 | $65,360 | $74,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | N/A | 50 | 0 |
| Accounts payable and accrued liabilities | 5,990 | 6,670 | 14,320 | 7,290 | 8,220 |
| Accrued Expenses | 2,810 | 3,760 | N/A | 3,390 | 2,050 |
| Other current liabilities | 4,890 | 5,260 | N/A | 5,090 | 6,550 |
| TOTAL | $13,700 | $15,700 | $14,320 | $15,840 | $16,830 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,790 | 23,990 | 51,460 | 15,490 | 26,810 |
| TOTAL | $49,640 | $58,650 | $51,460 | $51,340 | $65,880 |
| Total Liabilities | $63,350 | $74,360 | $65,780 | $67,190 | $82,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 2 | N/A |
| Common Shares | 122,790 | 122,790 | N/A | 111,100 | 109,280 |
| Retained earnings | -211,200 | -213,080 | N/A | -195,880 | -200,420 |
| Other shareholders' equity | 84,450 | 83,600 | -7,520 | 82,960 | 82,470 |
| TOTAL | $-3,960 | $-6,690 | $-7,520 | $-1,820 | $-8,670 |
| Total Liabilities And Equity | $59,390 | $67,670 | $58,260 | $65,370 | $74,060 |